New Teva Generics

Levothyroxine Sodium Tablets, USP

Brand Equivalent:
Synthroid®
Launch Date:
9/21/2022

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals)

Brand Equivalent:
Macrobid® (Nitrofurantoin Capsules, USP) (monohydrate/macrocrystals)
Launch Date:
9/9/2022

Icosapent Ethyl Capsules

Brand Equivalent:
Vascepa® Capsules
Launch Date:
9/9/2022

Tacrolimus Ointment

Brand Equivalent:
Protopic® (tacrolimus) Ointment
Launch Date:
9/9/2022

Mycophenolate Mofetil Tablets

Brand Equivalent:
CellCept® (mycophenolate mofetil) Tablets
Launch Date:
9/9/2022

Pantoprazole Sodium for Injection

Brand Equivalent:
Protonix® I.V. (pantoprazole sodium) for Injection
Launch Date:
9/9/2022

Mycophenolate Mofetil for Oral Suspension, USP

Brand Equivalent:
CellCept® Oral Suspension
Launch Date:
6/2/2022

Dalfampridine Extended-release Tablets

Brand Equivalent:
Ampyra® Extended Release Tablets
Launch Date:
5/31/2022

Lanthanum Carbonate Chewable Tablets

Brand Equivalent:
Fosrenol® chewable tablets
Launch Date:
5/25/2022

Scopolamine Transdermal System

Brand Equivalent:
Transderm Scop® Transdermal System
Launch Date:
5/12/2022

Pirfenidone Tablets

Brand Equivalent:
Esbriet® tablets
Launch Date:
5/11/2022

Looking for a different generic product?

View Teva's entire generics catalog